MY125900A - Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders - Google Patents

Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Info

Publication number
MY125900A
MY125900A MYPI9904471A MY125900A MY 125900 A MY125900 A MY 125900A MY PI9904471 A MYPI9904471 A MY PI9904471A MY 125900 A MY125900 A MY 125900A
Authority
MY
Malaysia
Prior art keywords
cyclooxygenase
inhibitors
prevention
cardiovascular disorders
disorders
Prior art date
Application number
Inventor
Barbara Roniker
Richard J Lachapelle
Daniel T Connolly
Karen Seibert
Philip Needleman
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Priority to MYPI9904471 priority Critical patent/MY125900A/en
Publication of MY125900A publication Critical patent/MY125900A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

THIS INVENTION RELATES TO THE USE OF CYCLOOXYGENASE-2 INHIBITORS OR DERIVATIVES THEREOF IN PREVENTING CARDIOVASCULAR DISORDERS.
MYPI9904471 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders MY125900A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Publications (1)

Publication Number Publication Date
MY125900A true MY125900A (en) 2006-08-30

Family

ID=47264570

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Country Status (1)

Country Link
MY (1) MY125900A (en)

Similar Documents

Publication Publication Date Title
AP9901674A0 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders.
MXPA03004832A (en) Compounds and their uses.
AU2001228309A1 (en) N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
MY127247A (en) New pharmaceutical composition
HK1086762A1 (en) Sulfonamide substituted imidazoquinolines
AP2003002857A0 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors.
IL132797A0 (en) Compounds and methods for the inhibition of the expression of vcam-1
IL160630A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL160648A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
MXPA03000066A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
HK1041407B (en) Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
MXPA03000694A (en) New use of lipase inhibitors.
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
DE60019586D1 (en) MYOSTATIN GENPROMOTER AND INHIBITION OF ITS ACTIVATION
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
WO1998022101A3 (en) Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
WO2002005848A3 (en) Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
WO2001056555A3 (en) Use of cox-2 inhibitors for the treatment of constipation
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
WO2004087066A3 (en) Hif-1 inhibitors
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
ZA200502909B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2.